OXXON THERAPEUTICS
Oxxon Therapeutics™ (Oxxon) is a company developing the next generation of innovative antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. To date, the company has built an initial pipeline through its patented Hi-8™ PrimeBoost immunotherapy platform, an approach that allows the rapid development of products to selectively stimulate and enhance potent immune responses against disease. The company has successfully completed phase II clinical programmes in melanoma and hepatitis B and has a third development programme underway in HIV. In addition, the company intends to leverage its enabling platform through partnerships with companies developing therapeutic and preventative vaccine products.
OXXON THERAPEUTICS
Industry:
Alternative Medicine Biotechnology Health Care Hospitality Medical
Founded:
1999-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.oxti.com
Total Employee:
1+
Status:
Active
Contact:
+4401865398100
Email Addresses:
[email protected]
Total Funding:
15 M GBP
Technology used in webpage:
Amazon Amazon California Region
Investors List
MVM Life Science Partners
MVM Life Science Partners investment in Venture Round - Oxxon Therapeutics
Neomed Management
Neomed Management investment in Venture Round - Oxxon Therapeutics
NIF Ventures
NIF Ventures investment in Venture Round - Oxxon Therapeutics
Quester Capital
Quester Capital investment in Venture Round - Oxxon Therapeutics
ISIS Capital Management
ISIS Capital Management investment in Venture Round - Oxxon Therapeutics
Gray Ghost Ventures
Gray Ghost Ventures investment in Venture Round - Oxxon Therapeutics
Official Site Inspections
http://www.oxti.com
- Host name: ec2-52-20-84-62.compute-1.amazonaws.com
- IP address: 52.20.84.62
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
